admission date:  [2124-2-29]              discharge date:   [2124-3-29]date of birth:  [2055-8-23]             sex:   mservice: medicineallergies:penicillinsattending:[first name3 (lf) 9598]chief complaint:hypotensionmajor surgical or invasive procedure:s/p central line placement x 2 (hd catheter)history of present illness:mr. [known lastname 2795] is a 68 yo with met renal cell carc admitted on[2124-2-29] for week 2 of high dose il-2 therapy.  his last dose wascomplicated by shock requiring dopamine and brief atrialfibrillation, spontaneously reverting back when dopamine waschanged to neo.  his current course was given from [2-29] to [3-4]and has been complicated by nausea/vomiting, encephalopathy,diarrhea, rigors, and desquamation, but also by hypotension inthe 70s systolic requiring neo for 90 min on [3-2] and restartedagain on [3-5], arf with decreasing uop (355 total cc's on [3-5],none on [3-4], + ~ 14l loc but without detailed recording of hisuop), and progressive metabolic acidosis despite bicarbinfusion.  vancomycin was started empirically in the setting ofsevere dermatitis, and he has been on prophylactic ciprothroughout his stay.  his last dose 9am on [3-4].  his cr hasrisen progressively from 1.9 on admission to 6.6 on the eveningof transfer.  because of his progressive renal failure, dopaminewas added to improve renal perfusion.  he was also transientlyin afib.  his tmax during his stay has been 99.5 on [3-1] with noother elevated temps, though he has been intermittently around95f..review of systems:(+)ve: as per hpi(-)ve: chest pain, palpitations, rhinorrhea, nasal congestion,cough, sputum production, hemoptysis, dyspnea, orthopnea,paroxysmal nocturnal dyspnea, constipation, hematochezia,melena, dysuria, urinary frequency, urinary urgency, focalnumbness, focal weaknesspast medical history:metastatic renal cell carcinoma, s/p nephrectomy.  metastatic tolung, adrenal gland, brain.  s/p cyberknife [12-19].bleeding ulcershtnhyperlipidemiagerddiverticulosismigrainesbarrett's esophagusanemia with folate deficiencyappendectomy in [2076]hemorrhoidectomy [2094]back surgery in [2113]vasectomysocial history:he is a chief of police in [location (un) 82875] police.he is married and he is seen with his wife today.  [name2 (ni) ] has twoadult children.  he does not smoke.  he has about five to eightglasses of bourbon weekly.family history:no history of any kidney cancer, but his motherhad ovarian cancer, no obvious signs of burkitt lymphoma, who isnow healthy.physical exam:97.8  119  105/44  16  100%2l.physical examgeneral: dry and desquamatedheent: normocephalic, atraumatic. conjunctival erythema. noscleral icterus. perrla/eomi but tracks slowly and incompletely.mucous membranes dry. op clear. neck supple, no lad, nothyromegaly.cardiac: regular rhythm, tachycardic. normal s1, s2. 2/6 sem inrusb, rubs or [last name (un) 549]. jvp=flatlungs: ctab, good air movement biaterally anteriorly.abdomen: hypoabs. soft, nt, nd. no hsmextremities: diffuse [3-15]+edema, 2+ dorsalis pedis/ posteriortibial pulses.skin: diffuse erythema and desquamation.  skin breakdown ongrown and buttocks.neuro: a&ox3 though with difficulty with word finding.appropriate. cn 2-12 intact. preserved sensation throughout. [6-14]strength throughout. gait assessment deferredpsych: listens and responds to questions appropriately.pertinent results:[2124-2-29] 09:49am   pt-13.9 ptt-21.6 inr(pt)-1.2[2124-2-29] 09:49am   plt count-386#[2124-2-29] 09:49am   wbc-8.0 rbc-3.21 hgb-9.5 hct-29.3 mcv-91mch-29.6 mchc-32.4 rdw-13.9[2124-2-29] 09:49am   albumin-3.4 calcium-8.1 phosphate-3.2magnesium-2.0[2124-2-29] 09:49am   alt(sgpt)-19 ast(sgot)-21 ld(ldh)-169ck(cpk)-55 tot bili-0.6[2124-2-29] 09:49am   estgfr-using this[2124-2-29] 09:49am   glucose-121 urea n-17 creat-1.6# sodium-144potassium-4.1 chloride-112 total co2-25 anion gap-11[2124-3-24] hand x-ray no previous images. the distal [hospital1 ] and adjacent soft tissuesareessentially within normal limits on the images presented. noevidence oferosions or dystrophic calcification.[2124-3-23] ct abd/pelvis1. small bowel dilation without a clear transition point tosuggestmechanical obstruction. a 7 cm segment of small bowel wallthickening mayrepresent ischemia, infection, or inflammation. a repeated ctwith i.v.contrast may help evaluate the transit of oral contrast as wellas themesenteric vasculature2. nasogastric tube just passed the gastroesophageal junction.considerreposition of nasogastric tube in the body of the stomach.3. metastatic disease, incompletely evaluated on thisnon-contrast study.4. bibasilar consolidative opacity concerning for pneumonia5. florid colonic diverticulosis without evidence ofdiverticulitis.6. decrease in size of right adrenal nodule suggestive ofresponse totherapy.7. extensive therosclerotis including coronary artery, abdominalaorta andmesenteric vessels.[2124-3-23]mri head1. near-complete interval resolution of the enhancing lesionwithin the left anterior temporal lobe. only minimal residualenhancement and flair signal hyperintensity persist. no newenhancing lesions are identified.tte [2124-3-6]:  the left atrium is elongated. left ventricularwall thickness, cavity size, and global systolic function arenormal (lvef>55%). due to suboptimal technical quality, a focalwall motion abnormality cannot be fully excluded. there is noventricular septal defect. right ventricular chamber size andfree wall motion are normal. the ascending aorta is mildlydilated. there is no aortic valve stenosis. no aorticregurgitation is seen. the mitral valve appears structurallynormal with trivial mitral regurgitation. the pulmonary arterysystolic pressure could not be determined. there is a smallpericardial effusion. there are no echocardiographic signs oftamponade.tte [2124-3-8]:  impression: small pericardial effusion locatedmostly posterior to the left ventricle. there is minimal fluidanterior to the right ventricle. there is significant,accentuated respiratory variation in mitral/tricuspid valveinflows, which can be consistent with impaired ventricularfilling but is more likely due to the irregularity of the heartrate. there is no frank tamponade seen. normal biventricularfunction. no evidence of endocarditis although the valves arenot well seen.compared with the prior study (images reviewed) of [2124-3-6],this is a limited study. the valves are not well seen. thepatient remains tachycardic but is now in atrial fibrillation.the size of the pericardial effusion is similarrenal ultrasound [2124-3-6]:1. no hydronephrosis of the right kidney. left kidney issurgically absent.cxr [2124-3-6]:lung volumes are lower, pulmonary vasculature more engorged, anddistendedmediastinal veins, unchanged, pointing toward volume overload orcardiacdecompensation. a more focal opacity at the left lung baselaterally would be better evaluated after hemodynamic status isoptimized. it could be a small region of infection orinfarction, pleural effusion, or transient atelectasis.heart is top normal size, though increased since yesterday.right subclavian line ends in the upper svc. no pneumothorax.ct head/chest non-con [2124-3-7]:slightly decreased vasogenic edema in region of known lefttemporal lobe metastasis.1. extensive new strikingly peripheral/subpleural ground-glassopacities with a slight upper lobe predominance is highlysuggestive of drug-induced toxicity (likely il-2 drug-inducedeosinophilic lung disease). the more confluent lower lobeopacities are most suggestive of atelectasis, although infectioncannot be excluded by imaging.2. persistent findings suggestive of vascular engorgement withmildinterstitial edema and small bilateral pleural effusions.3. no significant interval change to some of the previouslynoted metastatic lesions with many of the previously noted fociobscured by the new lung parenchymal opacities. slightenlargement of prevascular lymph nodes can be seen in thesetting of underlying pulmonary edema/elevated cvp.cxr [2124-3-8]:findings: as compared to the previous examination, a new centralvenousaccess line has been inserted over the left anterior jugularvein. the tip of the line projects over the upper svc. there isno evidence of complication, notably no pneumothorax.the other monitoring and support devices are in unchangedposition.also unchanged is the size of the cardiac silhouette and thebilateralmultifocal parenchymal opacities. the retrocardiac opacity couldhaveminimally increased in the interval.lower extremity u/s:impression: no evidence of dvt in either lower extremity. leftperoneal vein not well visualized.bal:  bronchial lavage, right mid lobe:  negative for malignant cells.  bronchial epithelial cells, pulmonary macrophages, and  neutrophils; no viral inclusions noted.cxr [2124-3-11]:tip of the endotracheal tube is no less than 48 mm from thecarina, standard placement for patient of this size. diffuseinfiltrative pulmonary abnormality, more pronounced in theperihilar right lung has progressed could by virtue of asymmetrybe pneumonia rather than pulmonary edema, although pulmonaryvascular congestion is present. the heart is moderatelyenlarged.  moderate right pleural effusion is stable. rightjugular line ends in the low svc, left jugular line in the midsvc, nasogastric tube passes below the diaphragm and out ofview. mediastinal widening in the right lower paratrachealstation is due to a combination of adenopathy and venousengorgement.portable abdomen [2124-3-10]:findings: supine ap abdomen radiograph demonstrates anasogastric tubefollowing a normal course and terminating in the distal stomach.there is no evidence of pneumoperitoneum. the bowel gas shadowappears unremarkable[2124-3-6] 7:08 am urine      source: catheter.                            final report [2124-3-8]   urine culture (final [2124-3-8]):      escherichia coli.    10,000-100,000 organisms/ml[2124-3-7] 4:21 pm urine      source: catheter.                            final report [2124-3-8]   urine culture (final [2124-3-8]):    no growthdirect influenza a antigen test (final [2124-3-7]):      negative for influenza a.   direct influenza b antigen test (final [2124-3-7]):      negative for influenza b.[2124-3-8] 4:22 am stool     consistency: soft      source: stool.                            final report [2124-3-10]   fecal culture (final [2124-3-9]):    no salmonella or shigellafound.   campylobacter culture (final [2124-3-10]):    no campylobacterfound.   clostridium difficile toxin a & b test (final [2124-3-8]):      feces negative for c.difficile toxin a & b by eia.           (reference range-negative).[2124-3-9] 10:09 am bronchoalveolar lavage   gram stain (final [2124-3-9]):      no polymorphonuclear leukocytes seen.      1+    (<1 per 1000x field):   gram positive cocci.                                    in pairs.   respiratory culture (final [2124-3-11]):      ~1000/ml commensal respiratory flora.   potassium hydroxide preparation (final [2124-3-9]):      test cancelled by laboratory.      patient credited.      this is a low yield procedure based on our in-housestudies if      pulmonary histoplasmosis, coccidioidomycosis,blastomycosis,      aspergillosis or mucormycosis is strongly suspected,contact the      microbiology laboratory (7-2306).   immunoflourescent test for pneumocystis jirovecii (carinii)(final      [2124-3-9]):    negative for pneumocystis jirovecii(carinii)..   fungal culture (preliminary):    no fungus isolated.   viral culture: r/o cytomegalovirus (preliminary):      no virus isolated so far.[2124-3-9] 10:09 am rapid respiratory viral screen & culture                            final report [2124-3-11]   respiratory viral culture (final [2124-3-11]):      no respiratory viruses isolated.      culture screened for adenovirus, influenza a & b,parainfluenza type      1,2 & 3, and respiratory syncytial virus..      detection of viruses other than those listed above willonly be      performed on specific request. please call virology at[telephone/fax (1) 6182]      within 1 week if additional testing is needed.   respiratory viral antigen screen (final [2124-3-9]):      negative for respiratory viral antigen.      specimen screened for: adeno, parainfluenza 1, 2, 3,influenza a, b,      and rsv by immunofluorescence.      refer to respiratory viral culture for furtherinformation.[2124-3-9] 12:11 pm sputum     site: endotracheal      source: endotracheal.   gram stain (final [2124-3-9]):      >25 pmns and <10 epithelial cells/100x field.      no microorganisms seen.   respiratory culture (final [2124-3-11]):    no growth.   fungal culture (preliminary):    no fungus isolated.[2124-3-6] 2:29 am blood culture      source: line-r sctl -> msra(+)[2124-3-10]:  vre blood culture from a-line[2124-3-11], [2124-3-12] blood cultures pendingbrief hospital course:#. shock: felt initially most likely due to sepsis and he wascovered broadly with antibiotics.  initially broadenedantibiotics to vanc/levo/cefepime to cover above sources.  goalcvp was [9-21], map > 65.  initial central venous o2 saturationwas 91%.  patient was transferred from floor to icu on dopamineand neo; dopamine was converted to levophed.  pulsus was normalat 5.  echocardiogram as above, largely unremarkable.hypotension persisted and was thought to be septic in etiologywith il-2 distributive physiology contributing.  shock wasrefractory to fluid boluses; received normal saline and waterwith bicarb given renal failure.  blood cultures eventually grewout mrsa, successive cultures negative until [2124-3-10], with[2124-3-10] culture growing vancomycin-resistant enterococcus.during this time, patient was actually weaned off pressors.  theright subclavian triple lumen was removed and a right internaljugular triple lumen was placed.  goals of care were discussedwith family, who requested continued aggressive treatment.linezolid replaced vancomycin for vre bacteremia. the patient'spressures stabilized and pressors were discontinued.  he did nothave further hypotension after transfer to the oncology floor.# mrsa/vre bacteremia: s/p line removals; patient completed 15day course of linezolid.  also added meropenem on [3-24] given msdecline and asterixis.  antibiotics were d/c'd on [3-25] andpatient has been stable, afebrile without leukocytosis since.repeat blood and urine cultures have been negative.# partial/early sbo: on [3-25] patient developed worseningabdominal distention and confusion.  this early sbo was likelydue to narcotics though concerning that is ongoing and limitingnutrition. mri head with improved findings. an ngt was placedfor 24 hours and the patient's ms cleared as did his sbo.  therewas initially some concern for messenteric ischemia given guiaicpositive stool, known necrotic fingers and subsequent ct abdfindings, so gi and surgery were consulted.  patient howeversoon improved clinically so further work-up with colonoscopy wasnot done.  he was able to tolerate a regular diet for 48h priorto discharge. a picc had been placed for access and for abilityto start tpn if needed, however tpn was never started.# anemia: likely multifactorial due to poor nutrition, acutenutrition, and marrow suppression.  patient is also fob+ s/p 2uprbc since [3-17]. then another 1u [3-24].  he was continued on iron,folate and b12 on [3-27].  mr. [known lastname 2795] did have guiaic positivestools during admission which should be followed-up  bygastroenterology as an outpatient.# gangrene: [3-14] pressors, shock as below.  patient was treatedwith wound care and transitioned to a fentanyl patch withbreakthrough morphine for pain.# thrombocytopenia: resolved. likely due to myelosuppression.# coagulopathy: patient was supplemented with vitamin k x3 daysto decrease his inr.#  respiratory failure- patient was intubated electively insetting of persistent hypervolemia and renal failure.maintained on minimal ventilatory support during dialysis.patient received antibiotic coverage for aspiration pneumonia.the patient was extubated on [2124-3-15] and continued to improvesignificantly. the patient was called out to the omed floor teamfor further managment.#. arf: il-2 mediated arf most likely, however prerenal orpostrenal etiology also possible.  k wnl, phos elevated thoughstable from last draw.  patient likely had il-2 induced renalinjury, with possible ischemic acute tubular necrosis.  despiteaggressive fluids, renal function did not improve.  patient wasshowing signs of uremia and hypervolemia, and continuous[last name (un) ]-venous hemodialysis was started following intubation andplacement of hd line.  on the last days of admission he did notrequire diuresis and continued to auto-diurese with a creatinineof 1.1-1.3. he was not continued on his anti-hypertensives ashis sbps were 130-140. mr. [known lastname 2795] should have his renal functionchecked as an outpatient in the next 1-2 weeks. if there areconcerns with worsening kidney function as an oupatient, heshould be followed by renal.#  atrial fibrillation with rapid ventricular response- occurredon morning of [2124-3-7].  became more hypotensive, received twoattempts at dc cardioversion, transient sinus rhythm restored,then converted back into a. fib.  amiodarone load and drip wasstarted.  converted to sinus rhythm day later, maintained onamio drip.  cardiac enzymes were flat, lower extremityultrasound negative for dvt.  repeat tte showed no right heartstrain. the amiodarone drip was discontinued and the patientremained in normal sinus rhythm.#. ha/ms changes: known metastatic disease to brain and il-2 cancause swelling.  he is aox3, though slightly agitated.  clinicalpicture not c/w meningitis/encephalitis and most likelytoxic-metabolic.  ct head showed slight improvement inmetastatic disease, less vasogenic edema.  lumbar puncture wasdeferred given intracranial mass. as patient stayed on theoncology floor his mental status gradually returned to [location 213].he can have a formal neurocognitive outpatient work-up if deemednecessary by his pcp.# skin/eye/mucous membrane breakdown: patient developedsignificant skin breakdown, particularly on his fingertipslikely due to pressors and il-2.  he was evaluated by plasticsurgery and hand x-ray found no need for intervention.  he wascontinued on: nystatin, miconazole, benadryl, sarna, hydrocerin,hydroxyzine, eye drops, gelclair.#. rcc: finished week 2 of il-2. maintained contact withoutpatient oncologist.code status: full (confirmed)medications on admission:medications upon transfer:hydrocerin 1 appl tp qid:prn dry skin50 meq sodium bicarbonate/1000 ml d5 1/2 ns continuous at 75ml/hrhydroxyzine 25-50 mg po/ng q6h:prn pruritislorazepam 0.5-1 mg po/iv q4h:prnacetaminophen 975 mg po q6h prnmeperidine 25-50 mg iv q2h:prn rigorsartificial tears preserv. free 1-2 drop both eyes prnmorphine sulfate 1-2 mg iv q2h:prn painciprofloxacin hcl 250 mg po/ng q24hpantoprazole 40 mg po q24hdopamine 4 mcg/kg/min iv dripphenylephrine 1 mcg/kg/min iv dripdiphenhydramine 25-50 mg po/iv q6h:prn pruritisdiphenoxylate-atropine [2-12] tab po prn after each loose stoolprochlorperazine 10 mg po/iv q6h:prn nausea/vomitingerythromycin nf 5 mg/g ou tidsarna lotion 1 appl tp qid:prn pruritusgabapentin 100 mg po/ng tid pruritusgelclair 15 ml oral tid:prn mucositisstopped aldesleukin 47.4 million units iv q8h on days 1, 2, 3,4 and 5..home medications:lipitor 20mgdiltiazem 240mg [hospital1 ]folate 1mg qdayprotonix 40mg qdaytriamterene/hydrochlorothiazide 75/50mg qdayvalsartan 320mg qdayvit c 1g qdaycitrucel 1g [hospital1 ]cyanocobalamin 1g sc monthlydischarge medications:1. lipitor 20 mg tablet sig: one (1) tablet po once a day.2. folic acid 1 mg tablet sig: one (1) tablet po daily (daily).3. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one(1) tablet, delayed release (e.c.) po q24h (every 24 hours).4. cyanocobalamin 1,000 mcg/ml solution sig: one (1)  injectiononce a month: next due [4-24].5. vitamin c 1,000 mg tablet sig: one (1) tablet po once a day.6. diphenhydramine hcl 25 mg capsule sig: [2-12] capsules po q6h(every 6 hours) as needed for pruritis.disp:60 capsule(s) refills:07. lorazepam 0.5 mg tablet sig: 1-2 tablets po q4h (every 4hours) as needed for nausea/vomiting, insomnia or anxiety.disp:30 tablet(s) refills:08. white petrolatum-mineral oil     cream sig: one (1) appltopical qid (4 times a day) as needed for dry skin.disp:qs 1 month refills:09. oral wound care products     gel in packet sig: fifteen (15)ml mucous membrane tid (3 times a day) as needed for mucositis.disp:qs 1 month refills:010. hydroxyzine hcl 25 mg tablet sig: one (1) tablet po q6h(every 6 hours) as needed for pruritis.disp:60 tablet(s) refills:011. camphor-menthol 0.5-0.5 % lotion sig: one (1) appl topicalqid (4 times a day) as needed for pruritus.disp:qs 1 month refills:212. acetaminophen 650 mg tablet sig: one (1) tablet po every six(6) hours as needed for pain: do note take more than 4 grams perday.disp:120 tablet(s) refills:013. ferrous gluconate 325 mg (37.5 mg iron) tablet sig: one (1)tablet po bid (2 times a day).disp:60 tablet(s) refills:214. fentanyl 25 mcg/hr patch 72 hr sig: one (1) patch 72 hrtransdermal q72h (every 72 hours): remove previous  patch beforeapplying. do not drive while using this.disp:20 patch 72 hr(s) refills:015. morphine 15 mg tablet sig: 1-2 tablets po q4h (every 4hours) as needed for pain.disp:60 tablet(s) refills:016. docusate sodium 100 mg capsule sig: one (1) capsule po bid(2 times a day).disp:60 capsule(s) refills:217. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times aday).disp:60 tablet(s) refills:218. polyethylene glycol 3350 17 gram/dose powder sig: one (1)pkt po daily (daily) as needed for constipation.disp:60 pkt refills:219. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2)tablet, delayed release (e.c.) po daily (daily) as needed forconstipation.disp:60 tablet, delayed release (e.c.)(s) refills:220. zofran odt 8 mg tablet, rapid dissolve sig: one (1) tablet,rapid dissolve po every eight (8) hours as needed for nausea.disp:30 tablet, rapid dissolve(s) refills:1discharge disposition:home with servicefacility:[hospital ] health caredischarge diagnosis:primary:metastatic rcca - s/p c1w2 hd il-2 therapysecondary:vre/mrsa sepsisacute renal failure, resolvedsbo, resolvedperipheral necrosis of digitsacute mental status changes, resolveddischarge condition:alert, oriented, ambulatorydischarge instructions:you were admitted to [hospital1 69] foril-2 therapy for your renal cell carcinoma.  while you were hereyou had a very complicated hospital course.-you developed bacteria in your blood and you were treated withantibiotics for mrsa and vre. you have finished your courses ofantibiotics and your blood cultures have been normal.-you had a uti with e-coli and you were treated withantibiotics. your urine cultures have since been normal.-you needed dialysis.  your kidney function has since improvedand your creatinine was 1.2 at discharge.  this should bemonitored closely and you should see a renal doctor if itworsens.-you were in the intensive care unit and you were intubated forconfusion.  this improved. you should ask dr. [last name (stitle) ] ifneurocognitive evaluation is needed.-you had necrosis (damage) to your fingertips from some of themedications in the icu.  plastic surgery saw you and your fingertips started to improve.-you also had skin damage to your sacrum (above your buttocks)from the il-2.  the vna services should help you change thesedressings.while you were here some of your medications were changed.you should continue taking:lipitor 20mgfolate 1mg qdayprotonix 40mg qdayvit c 1g qdaycyanocobalamin 1g sc monthly  (you received this on [3-27])you should stop taking:citrucel 1g [hospital1 ]diltiazem 240mg [hospital1 ]triamterene/hydrochlorothiazide 75/50mg qdayvalsartan 320mg qdayyou should start taking:benadryl, hydroxyzine, camphor-methol, petrolatum-mineral oil asneeded for itchinglorazepam as needed for nausea, vomiting or anxiety (do notdrive or drink alcohol while taking this)oral care and wound care productstylenol as needed for painferrous gluconate twice a dayfentanyl patch every 72 hours (do not drive or drink alcoholwhile taking this)morphine as needed for pain (do not drive or drink alcohol whiletaking this)you should take senna and colace every day to preventconstipation and take miralax and bisacodyl if you becomeconstipated.notify [first name8 (namepattern2) ] [last name (namepattern1) ], rn, at ([telephone/fax (1) 82663] for fever, chills,shortness of breath, or inability to take oral fluidsfollowup instructions:you have the following appointment's with dr. [last name (stitle) 1729],[telephone/fax (1) 22].[2124-4-25]  02:00p   xct (tcc) [apartment address(1) ]: catscan appointment[hospital6 29], [location (un) ][2124-5-2]  02:30p   [doctor last name ],tuesday biologicssc [hospital ward name ] clinical ctr, [location (un) ]dr. [last name (stitle) 82876] [doctor first name 82877] pcp [telephone/fax (1) 82878][4-3] at 2:15pmwe will fax a copy of your discharge paperwork to dr. [last name (stitle) ].visiting nursing: [telephone/fax (1) 82879]                             [name6 (md) ] [last name (namepattern4) 9601] md, [md number(3) 9602]